Abstract
Guidelines indicate a plasma HIV-1 RNA load of 500-1000 copies/mL as the minimal threshold for antiretroviral drug resistance testing. Resistance testing at lower viral load levels may be useful to guide timely treatment switches, although data on the clinical utility of this remain limited. We report here the influence of viral load levels on the probability of detecting drug resistance mutations (DRMs) and other mutations by routine genotypic testing in a large multicentre European cohort, with a focus on tests performed at a viral load <1000 copies/mL.
| Lingua originale | Inglese |
|---|---|
| pagine (da-a) | 1886-1896 |
| Numero di pagine | 11 |
| Rivista | Journal of Antimicrobial Chemotherapy |
| Volume | 66 |
| DOI | |
| Stato di pubblicazione | Pubblicato - 2011 |
OSS delle Nazioni Unite
Questo processo contribuisce al raggiungimento dei seguenti obiettivi di sviluppo sostenibile
-
SDG 3 Salute e benessere
Keywords
- Adult
- Anti-HIV Agents
- CD4 Lymphocyte Count
- Cohort Studies
- Drug Resistance, Viral
- Europe
- Female
- Genotype
- HIV Infections
- HIV-1
- Humans
- Male
- Mutation, Missense
- RNA, Viral
- Viral Load
- Viral Proteins
Fingerprint
Entra nei temi di ricerca di 'Detection of drug resistance mutations at low plasma HIV-1 RNA load in a European multicentre cohort study'. Insieme formano una fingerprint unica.Cita questo
- APA
- Author
- BIBTEX
- Harvard
- Standard
- RIS
- Vancouver